Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
LGBT Health ; 11(2): 164-169, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-37815823

RESUMO

Purpose: The unique psychosocial experiences of nonbinary individuals across the lifespan are understudied compared with those of binary transgender individuals. This study examined the psychosocial stressors faced by nonbinary youth compared with their binary transgender counterparts at the time of gender-affirming hormone (GAH) readiness assessment. Methods: This study compared the psychosocial functioning of nonbinary youth with their binary transgender peers, ages 14-18, utilizing the Youth Self Report (YSR) at the time of GAH readiness assessment. Clinically relevant subscale scores of the YSR were analyzed. Results: Data from 479 binary and 55 nonbinary individuals were analyzed for this study. Analysis found that nonbinary youth reported substantially more psychosocial distress in the form of total problems (ß = 2.86, 95% confidence interval [CI] [0.15-5.56]), internalizing problems (ß = 4.57, 95% CI [1.55-7.59]), depression (ß = 4.52, 95% CI [1.70-7.33]), and self-harm (odds ratio 2.65, 95% CI [1.26-5.56]) than their binary transgender peers. Conclusion: Nonbinary youth experienced higher psychosocial distress compared with their binary transgender counterparts. Future research is needed to better understand the possible health disparities experienced by nonbinary people across their lifespan so that their psychosocial needs can be better met.


Assuntos
Funcionamento Psicossocial , Pessoas Transgênero , Humanos , Adolescente , Identidade de Gênero , Pessoas Transgênero/psicologia , Autorrelato , Hormônios
2.
Horm Res Paediatr ; 96(3): 267-277, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36007499

RESUMO

INTRODUCTION: Children with self-limited delayed puberty (DP) (constitutional delay) enter puberty after variable waiting times, and the factors associated with their eventual pubertal timing are not well understood. METHODS: We conducted a retrospective study of 99 girls and 228 boys with self-limited DP at an academic medical center between 2000 and 2015. To define features and potential subtypes of self-limited DP, we performed group-based trajectory modeling on childhood growth and latent-variable factor analysis on clinical characteristics. We then conducted time-to-event analyses to identify associations with pubertal timing. RESULTS: We identified two distinct growth trajectories in individuals with self-limited DP: one with stable and the other with declining height percentiles. Latent-variable factor analysis identified five factors underlying clinical variation that appear to correspond to genetic height potential, body mass index, childhood growth, parental pubertal delay, and medical issues (attention-deficit/hyperactivity disorder and inhaled glucocorticoid use). We observed correlations between pubertal timing and bone age (p = 0.01), childhood height (p = 0.004), and midparental target height (p < 0.001), but not with parental pubertal delay or with testosterone treatment in boys. CONCLUSIONS: By illustrating the heterogeneity within self-limited DP and identifying factors underlying this heterogeneity, our study suggests that there may be multiple causes of self-limited DP. However, our ability to determine when puberty will eventually occur remains limited. Dissecting self-limited DP into its component subtypes may inform future studies of the mechanisms contributing to pubertal delay as well as studies of the short- and long-term outcomes of self-limited DP.


Assuntos
Puberdade Tardia , Masculino , Criança , Feminino , Humanos , Puberdade Tardia/tratamento farmacológico , Estudos Retrospectivos , Puberdade/genética , Testosterona/uso terapêutico , Índice de Massa Corporal , Estatura
3.
J Clin Endocrinol Metab ; 106(9): e3693-e3703, 2021 08 18.
Artigo em Inglês | MEDLINE | ID: mdl-33890108

RESUMO

CONTEXT: The decision whether to treat a child with delayed puberty with sex steroids is primarily based on patient, family, and provider preference. Knowing when children with constitutional delay eventually enter puberty would inform this decision. OBJECTIVE, DESIGN, SETTING, PARTICIPANTS, AND OUTCOME MEASURES: To estimate and compare rates of pubertal entry, we conducted a retrospective cohort study by reviewing medical records of children evaluated for delayed puberty at a large academic medical center between 2000 and 2015, extracting data on pubertal status for all clinical visits, then conducting time-to-event analyses. RESULTS: Of 392 girls and 683 boys with delayed puberty, constitutional delay was the most common cause, found in 32% of girls and 70% of boys. In a subcohort of 97 girls and 243 boys who were prepubertal at one or more visits, we observed a broad age range for pubertal entry, up to >16 years for girls and >17 years for boys. The probability of entering puberty within the next year for 12- to 15.5-year-old girls and 13.5- to 16.5-year-old boys with delayed puberty ranged between 38% and 74%. No differences in the rates of pubertal entry were seen between girls and boys after data harmonization. CONCLUSION: The broad range of ages at pubertal entry for children with constitutional delay challenges the concept that constitutional delay is merely an extreme of normal variation. Discussions with patients and families about management should consider the possibility that some children may need to wait years after presentation until puberty starts.


Assuntos
Deficiências do Desenvolvimento/fisiopatologia , Puberdade Tardia/fisiopatologia , Puberdade , Adolescente , Fatores Etários , Composição Corporal , Criança , Estudos de Coortes , Feminino , Humanos , Hipogonadismo/complicações , Hipogonadismo/fisiopatologia , Masculino , Puberdade Tardia/epidemiologia , Puberdade Tardia/etiologia , Estudos Retrospectivos , Caracteres Sexuais
4.
Horm Res Paediatr ; 92(3): 186-195, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31865343

RESUMO

INTRODUCTION: Short stature is one of the most common reasons for referral to a pediatric endocrinologist and can result from many etiologies. However, many patients with short stature do not receive a definitive diagnosis. OBJECTIVE: To ascertain whether integrating targeted bioinformatics searches of electronic health records (EHRs) combined with genomic studies could identify patients with previously undiagnosed rare genetic etiologies of short stature. We focused on a specific rare phenotypic subgroup: patients with short stature and elevated IGF-I levels. METHODS: We performed a cross-sectional cohort study at three large academic pediatric healthcare networks. Eligible subjects included children with heights below -2 SD, IGF-I levels >90th percentile, and no known etiology for short stature. We performed a search of the EHRs to identify eligible patients. Patients were then recruited for phenotyping followed by exome sequencing and in vitro assays of IGF1R function. RESULTS: A total of 234 patients were identified by the bioinformatics algorithm with 39 deemed eligible after manual review (17%). Of those, 9 were successfully recruited. A genetic etiology was identified in 3 of the 9 patients including 2 novel variants in IGF1R and a de novo variant in CHD2. In vitro studies supported the pathogenicity of the IGF1R variants. CONCLUSIONS: This study provides proof of principle that patients with rare phenotypic subgroups can be identified based on discrete data elements in the EHRs. Although limitations exist to fully automating this approach, these searches may help find patients with previously unidentified rare genetic disorders.


Assuntos
Estatura/genética , Transtornos do Crescimento/genética , Fator de Crescimento Insulin-Like I/análise , Fenótipo , Adolescente , Criança , Pré-Escolar , Estudos de Coortes , Estudos Transversais , Proteínas de Ligação a DNA/genética , Registros Eletrônicos de Saúde , Feminino , Células HEK293 , Humanos , Masculino , Mutação de Sentido Incorreto , Receptor IGF Tipo 1/química , Receptor IGF Tipo 1/genética , Receptor IGF Tipo 1/fisiologia , Sequenciamento do Exoma
5.
J Clin Endocrinol Metab ; 104(10): 4578-4586, 2019 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-31194243

RESUMO

CONTEXT: Variation in pubertal timing is associated with a wide range of adult risks and outcomes, but it is unclear whether these associations are causal, and it is largely unknown whether these associations can be modified by treatment. EVIDENCE ACQUISITION: We conducted PubMed searches to identify Mendelian randomization (MR) studies on the influence of pubertal timing on adult health and studies on sex-steroid treatment of the following conditions associated with reduced reproductive endocrine function in adolescence: constitutional delay, Turner syndrome, and Klinefelter syndrome. EVIDENCE SYNTHESIS: Results of MR studies suggest that earlier pubertal timing increases body mass index; increases risk for breast, ovarian, endometrial, and prostate cancers; elevates fasting glucose levels and blood pressure; impairs lung capacity and increases risk for asthma; leads to earlier sexual intercourse and first birth; decreases time spent in education; and increases depressive symptoms in adolescence. Later pubertal timing appears to lower bone mineral density (BMD). Although studies of constitutional delay have not shown that sex-steroid treatment alters adult height or BMD, studies of girls with Turner syndrome and boys with Klinefelter syndrome suggest that earlier initiation of sex-steroid treatment improves physical and neurocognitive outcomes. CONCLUSIONS: Despite having some limitations, MR studies suggest that pubertal timing causally influences many adult conditions and disease risks. Studies of Turner syndrome and Klinefelter syndrome suggest that earlier sex-steroid exposure may have short- and long-term benefits. The mechanisms underlying these findings and the effects of trends and treatments affecting pubertal timing remain to be determined.


Assuntos
Androgênios/metabolismo , Asma/epidemiologia , Pressão Sanguínea , Densidade Óssea , Depressão/epidemiologia , Estrogênios/metabolismo , Neoplasias/epidemiologia , Puberdade/metabolismo , Fatores Etários , Androgênios/uso terapêutico , Glicemia/metabolismo , Estatura , Índice de Massa Corporal , Neoplasias da Mama/epidemiologia , Causalidade , Coito , Neoplasias do Endométrio/epidemiologia , Estrogênios/uso terapêutico , Feminino , Humanos , Síndrome de Klinefelter/tratamento farmacológico , Medidas de Volume Pulmonar , Masculino , Idade Materna , Análise da Randomização Mendeliana , Neoplasias Ovarianas/epidemiologia , Neoplasias da Próstata/epidemiologia , Puberdade Tardia/tratamento farmacológico , Testosterona/uso terapêutico , Fatores de Tempo , Síndrome de Turner/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...